COVID-19 vaccination in France

COVID-19 vaccination in France started on 27 December, 2020 after the approval of Pfizer/BioNTech vaccine by the European Union commission.

Pfizer vaccines ready to be injected in a vaccination center on January 8, 2020 in Strasbourg.

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

Vaccine Approval Deployment
Pfizer–BioNTech COVID-19 vaccine 21 December 2020 27 December 2020
Moderna 6 January 2021 12 January 2021
Oxford-AstraZeneca 29 January 2021 6 February 2021

Vaccination strategy

The vaccination strategy put in place by the government has three principle objectives:[1]

  1. Reduce mortality and severe forms of the disease
  2. Protect caregivers and the healthcare system
  3. Ensure vaccine and immunization safety

The vaccine is planned to be distributed in five phases.

Phase 1
Vaccination of a health worker at the Strasbourg University Hospital on January 8, 2021.

The first phase of vaccination concerns the highest priority audiences. Since December 27, 2020, it initially concerned nursing home and ESMS residents and staff over the age of 50. Vaccination has been open to caregivers over 50 since January 2, then to firefighters and domestic caregivers over 50 since January 5.

Phase 2
Vaccination of people aged over 75 in Strasbourg on January 18, 2021.

This phase concerns people at high risk. From January 18, people aged 75 and over who do not reside in ESMS or nursing homes can be vaccinated. This phase will last until the end of February and concerns 5 million people. From the end of February, the vaccination will be open to people aged 65 to 74.

Phase 3

This phase concerns people who are more vulnerable than the general population. It will take place in the spring and include the following people.

  • People aged 50 to 64.
  • Precarious people and the staff accompanying them.
  • People living in closed places or in collective accommodation.
  • People with co-morbidities (COPD, hypertension, coronary heart disease, renal failure, cancers less than 3 years old or in progress, Trisomy 21, type I and II diabetes, obesity, people who have received organ or cell transplants strains).
  • People working in an essential sector and in contact with the public (education, security, food.).

Phase 4 & 5

Phases 4 and 5 will allow vaccination to be widely opened to those over 18.

Progress to date

Daily updates are provided by the Santé Public France.[2]

References
  1. "La stratégie vaccinale" (Press release). Ministère des Solidarités et de la Santé. 4 December 2020. Retrieved 30 January 2021.
  2. "Données relatives aux personnes vaccinées contre la Covid-19" (Press release). Santé publique France. Retrieved 30 January 2021.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.